NISHIO J[au] - Search Results

Year	Number of Results
1954	2
1969	1
1970	1
1971	1
1972	1
1974	2
1975	2
1976	5
1977	1
1978	2
1979	3
1980	1
1981	2
1982	1
1983	4
1984	1
1985	7
1986	6
1987	4
1988	4
1990	2
1991	6
1992	8
1993	3
1994	2
1995	5
1996	3
1997	5
1998	6
1999	4
2000	1
2001	11
2002	16
2003	7
2004	6
2005	5
2006	7
2007	2
2008	5
2009	8
2010	10
2011	13
2012	18
2013	16
2014	13
2015	10
2016	5
2017	4
2018	4
2019	3
2020	3
2021	11
2022	8

1

Biology and Management of Dedifferentiated Liposarcoma: State of the Art and Perspectives.

Nishio J, Nakayama S, Nabeshima K, Yamamoto T. Nishio J, et al. J Clin Med. 2021 Jul 22;10(15):3230. doi: 10.3390/jcm10153230. J Clin Med. 2021. PMID: 34362013 Free PMC article. Review.

2

Ubiquitin-specific Peptidase 6 (USP6)-associated Fibroblastic/Myofibroblastic Tumors: Evolving Concepts.

Nakayama S, Nishio J, Aoki M, Koga K, Nabeshima K, Yamamoto T. Nakayama S, et al. Among authors: nishio j. Cancer Genomics Proteomics. 2021 Mar-Apr;18(2):93-101. doi: 10.21873/cgp.20244. Cancer Genomics Proteomics. 2021. PMID: 33608306 Free PMC article. Review.

3

Immunoregulation by the gut microbiota.

Nishio J, Honda K. Nishio J, et al. Cell Mol Life Sci. 2012 Nov;69(21):3635-50. doi: 10.1007/s00018-012-0993-6. Epub 2012 Apr 22. Cell Mol Life Sci. 2012. PMID: 22527722 Review.

4

Inflammatory Biomarkers in Cancer.

Nakamura T, Gaston CL, Reddy K, Iwata S, Nishio J. Nakamura T, et al. Among authors: nishio j. Mediators Inflamm. 2016;2016:7282797. doi: 10.1155/2016/7282797. Epub 2016 Oct 23. Mediators Inflamm. 2016. PMID: 27843202 Free PMC article. No abstract available.

5

Current Update on the Diagnosis, Management and Pathogenesis of Elastofibroma Dorsi.

Nishio J, Nakayama S, Nabeshima K, Yamamoto T. Nishio J, et al. Anticancer Res. 2021 May;41(5):2211-2215. doi: 10.21873/anticanres.14997. Anticancer Res. 2021. PMID: 33952447 Review.

6

An Update on Clinicopathological, Imaging and Genetic Features of Desmoplastic Fibroblastoma (Collagenous Fibroma).

Nakayama S, Nishio J, Aoki M, Nabeshima K, Yamamoto T. Nakayama S, et al. Among authors: nishio j. In Vivo. 2021 Jan-Feb;35(1):69-73. doi: 10.21873/invivo.12233. In Vivo. 2021. PMID: 33402451 Free PMC article. Review.

7

Rationale for and clinical development of anti-fractalkine antibody in rheumatic diseases.

Muraoka S, Nishio J, Kuboi Y, Imai T, Nanki T. Muraoka S, et al. Among authors: nishio j. Expert Opin Biol Ther. 2020 Nov;20(11):1309-1319. doi: 10.1080/14712598.2020.1764931. Epub 2020 May 13. Expert Opin Biol Ther. 2020. PMID: 32401060 Review.

8

Identification and characterization of a novel Enterococcus bacteriophage with potential to ameliorate murine colitis.

Nishio J, Negishi H, Yasui-Kato M, Miki S, Miyanaga K, Aoki K, Mizusawa T, Ueno M, Ainai A, Muratani M, Hangai S, Yanai H, Hasegawa H, Ishii Y, Tanji Y, Taniguchi T. Nishio J, et al. Sci Rep. 2021 Oct 12;11(1):20231. doi: 10.1038/s41598-021-99602-4. Sci Rep. 2021. PMID: 34642357 Free PMC article.

9

Contributions of cytogenetics and molecular cytogenetics to the diagnosis of adipocytic tumors.

Nishio J. Nishio J. J Biomed Biotechnol. 2011;2011:524067. doi: 10.1155/2011/524067. Epub 2011 Jan 11. J Biomed Biotechnol. 2011. PMID: 21274402 Free PMC article. Review.

10

Morphological Correlations in Nasolabial Formation After Primary Lip Repair for Unilateral Cleft Lip.

Yamanishi T, Kondo T, Kirikoshi S, Otsuki K, Uematsu S, Nishio J. Yamanishi T, et al. Among authors: nishio j. J Oral Maxillofac Surg. 2021 Oct;79(10):2126-2133. doi: 10.1016/j.joms.2021.05.019. Epub 2021 May 19. J Oral Maxillofac Surg. 2021. PMID: 34161809

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results